COVID-19-Impfstoff Spikevax von Moderna - beantwortet durch 1568/AB

This procedure involves a formal response to a parliamentary inquiry in the Austrian National Council concerning the Moderna Spikevax COVID-19 vaccine. It serves as a mechanism for legislative oversight regarding public health measures and pharmaceutical products used during the pandemic. The inquiry affects public health authorities and citizens in Austria by providing transparency on vaccine-related information and government responses during the COVID-19 crisis.